Status:
NOT_YET_RECRUITING
Detection of Atrial Fibrillation Through Voice Signal Processing
Lead Sponsor:
Vital Audio Inc
Collaborating Sponsors:
Minneapolis Heart Institute Foundation
Conditions:
Atrial Fibrillation (AF)
Atrial Flutter
Eligibility:
All Genders
18+ years
Brief Summary
This study is testing a new technology that listens to a person's voice during short phone calls to help identify heart rhythm problems. The goal is to see if voice signal analysis can tell the differ...
Detailed Description
This is a prospective, single-center cohort study of 40 patients undergoing cardioversion for atrial fibrillation at the Minneapolis Heart Institute Foundation. The study is designed to evaluate wheth...
Eligibility Criteria
Inclusion
- To participate in this study, patients must meet all of the following inclusion criteria:
- Diagnosis of atrial fibrillation and presenting for cardioversion at Allina Health in atrial fibrillation
- 3\. ≥ 18 years of age Written informed consent obtained from patient in English
Exclusion
- Patients who meet any of the following criteria must be excluded from this study:
- History of a pacemaker
- History of dysphasia or difficulty with word finding
- History of vocal cord dysfunction
- Patient with atrial flutter as presenting arrhythmia
- Planned transesophageal echocardiogram (TEE) with cardioversion
Key Trial Info
Start Date :
October 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07212816
Start Date
October 15 2025
End Date
November 30 2025
Last Update
October 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.